SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Debiopharm Presented Results at the American Society of Clinical Oncology 2012 Annual Meeting - Results of Phase I Study With Debio 0932, an Oral HSP90 Inhibitor in Patients With Solid Tumours